EP1608417A4 - Method and system for colloid exchange therapy - Google Patents

Method and system for colloid exchange therapy

Info

Publication number
EP1608417A4
EP1608417A4 EP03726057A EP03726057A EP1608417A4 EP 1608417 A4 EP1608417 A4 EP 1608417A4 EP 03726057 A EP03726057 A EP 03726057A EP 03726057 A EP03726057 A EP 03726057A EP 1608417 A4 EP1608417 A4 EP 1608417A4
Authority
EP
European Patent Office
Prior art keywords
exchange therapy
colloid
colloid exchange
therapy
exchange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03726057A
Other languages
German (de)
French (fr)
Other versions
EP1608417A1 (en
Inventor
David Radunsky
James M D Matson
Patrice Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunocept LLC
Original Assignee
Immunocept LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunocept LLC filed Critical Immunocept LLC
Publication of EP1608417A1 publication Critical patent/EP1608417A1/en
Publication of EP1608417A4 publication Critical patent/EP1608417A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424Substitution fluid path
    • A61M1/3437Substitution fluid path downstream of the filter, e.g. post-dilution with filtrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3455Substitution fluids
    • A61M1/3468Substitution fluids using treated filtrate as substitution fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
EP03726057A 2003-03-13 2003-03-13 Method and system for colloid exchange therapy Withdrawn EP1608417A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/007784 WO2004082744A1 (en) 2003-03-13 2003-03-13 Method and system for colloid exchange therapy

Publications (2)

Publication Number Publication Date
EP1608417A1 EP1608417A1 (en) 2005-12-28
EP1608417A4 true EP1608417A4 (en) 2008-07-30

Family

ID=33029240

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03726057A Withdrawn EP1608417A4 (en) 2003-03-13 2003-03-13 Method and system for colloid exchange therapy

Country Status (3)

Country Link
EP (1) EP1608417A4 (en)
AU (1) AU2003228309A1 (en)
WO (1) WO2004082744A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131250A1 (en) * 2013-07-25 2015-01-25 Warsaw Medical University BLOOD PURIFICATION SYSTEMS AND DEVICES WITH INTERNALLY GENERATED REPLACEMENT FLUID

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015253A2 (en) * 1990-03-30 1991-10-17 Baxter International Inc. Multiple fluid source isolation, metering and alarm system and method
WO2000002603A2 (en) * 1998-07-10 2000-01-20 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612137A1 (en) * 1986-04-10 1987-10-15 Biotest Pharma Gmbh STERILE PLASMA REPLACEMENT
US5919369A (en) * 1992-02-06 1999-07-06 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5571418A (en) * 1993-08-20 1996-11-05 Lee; Patrice A. Hemofiltration of toxic mediator-related disease
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6193681B1 (en) * 1998-09-14 2001-02-27 American Immuno Tech, Llc. Septicemia prevention and treatment system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015253A2 (en) * 1990-03-30 1991-10-17 Baxter International Inc. Multiple fluid source isolation, metering and alarm system and method
WO2000002603A2 (en) * 1998-07-10 2000-01-20 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease

Also Published As

Publication number Publication date
AU2003228309A1 (en) 2004-10-11
WO2004082744A1 (en) 2004-09-30
EP1608417A1 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
AU2003282580A8 (en) Contrast therapy system and method
GB2407684C (en) Transaction method and system
GB2398810B (en) Well treatment method and system
EP1683303A4 (en) Method and system for connection verification
TWI348101B (en) Computing system, computing method and computing core device
HK1084256A1 (en) System and method for rate assignment
HK1073045A1 (en) Roaming-service-enabling system and method
AU2003243646A8 (en) System and method for facilitating ridesharing
EP1614087A4 (en) System, apparatus and method for mapping
IL162740A0 (en) Device, method and system for reduced transmissionimaging
EP1606121A4 (en) System and method for authenticating objects
IL174695A0 (en) Planning system, method and apparatus for conformal radiation therapy
AU2003302327A8 (en) System and method for below-market trading
GB2403429A8 (en) System and method for placing side wagers
EP1684666A4 (en) Aneurysm treatment system and method
EP1485259A4 (en) Device, system and method for data exchange
EP1676392A4 (en) System and method for secure access
AU2003284091A8 (en) Connection verification apparatus, system, and method
IL230822A0 (en) System and method for providing definitions
SG111110A1 (en) Validation system and method
EP1695173A4 (en) System and method for functional elements
AU2003284325A8 (en) Method and system for medical communications
GB2390439B (en) Dataconferencing system and method
GB0526213D0 (en) Method and system for giving
GB0227636D0 (en) Positioning method system and unit

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080630

17Q First examination report despatched

Effective date: 20080919

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110719